Last reviewed · How we verify
NCT05292170
Influences of Female Sex and Reproductive Hormones on Physiological Aspects of Heat Acclimation
NA trial testing Heat acclimation in Heat Stress, Exertional in 27 participants. Completed in 30 April 2024.
30 April 2024
Quick facts
| Lead sponsor | United States Army Research Institute of Environmental Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 27 |
| Start date | 1 October 2021 |
| Primary completion | 30 April 2024 |
| Estimated completion | 30 April 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Heat acclimation
Conditions studied
- Heat Stress, Exertional — all drugs for Heat Stress, Exertional →
Sponsor
United States Army Research Institute of Environmental Medicine
Who can join
Adults 18 to 40, any sex, with Heat Stress, Exertional. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Women are often understudied in thermal physiology research, leaving recommendations for Soldier safety and performance in hot conditions based largely on data collected in men. Female sex hormones estradiol and progesterone clearly have non-reproductive physiological effects, including influences on thermoregulatory and cardiovascular function. However, mechanisms of differing physiological adaptations to repeated heat exposure (i.e., heat acclimation) as a function of reproductive hormone status have yet to be investigated in a systematic way. Understanding possible sex differences in adaptation or mechanisms for adaptation during heat acclimation is important to ultimately optimize interventions to maximize soldier health and safety during training and deployment in the heat. Our goals in the present study are to evaluate physiological and biophysical responses to a standard heat acclimation protocol in a group of young, healthy men and women. Thirty individuals (n=10 males, n=10 women with a low hormonal status (i.e. early follicular phase), n=10 women with a high hormonal status (i.e. midluteal phase)) will complete 10 consecutive days of exercise (treadmill walking: 3.1 mph/2% grade) in the heat (40°C /40% relative humidity) up to 3hr per day. Changes in core temperature, heart rate, and sex hormones will be assessed to examine differences in thermoregulatory response to heat acclimation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Inter-individual variability in physiological adaptations during heat acclimation in adults: Contributions of body mass index and body size.
Brazelton SC, Charkoudian N, Bradbury KE, Salgado RM, et al · · 2026 · cited 1× · PMID 41546148 · DOI 10.14814/phy2.70713
Verify or expand the search:
- PubMed search for NCT05292170
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Heat acclimation
Trials testing the same drug.
- NCT05838612 — Hot Water Immersion as a Heat Acclimation Strategy in Older Adults · NA · completed
- NCT07198334 — The Effect of Daily Brief Heat Exposures on Heat Acclimation · NA · completed
- NCT05600452 — Comparison of a Novel Condensed Heat Acclimation Programme With a Traditional Longer-term Heat Acclimation Programme · NA · completed
- NCT04053465 — Heat Acclimation, Hand Cooling Efficacy, and Adaptation Maintenance. · NA · completed
Other United States Army Research Institute of Environmental Medicine trials
Trials by the same sponsor.
- NCT07489690 — Energy Dense Fueling for Cold-Weather Operations · NA · recruiting
- NCT07099872 — Chronic Exercise With Overdressing · NA · completed
- NCT06468748 — The Effects of Semaglutide on Body Composition and Performance in Military Personnel · Phase 4 · withdrawn
- NCT07063173 — Bioavailability of Ration Items Containing Tart Cherry Extract · NA · recruiting
- NCT06073080 — Recovery Protein Nutrition as a Countermeasure for Anabolic Resistance Following Sleep Loss · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05292170 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by United States Army Research Institute of Environmental Medicine
- Last refreshed: 7 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05292170.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing